New hope for lymphoma patients: experimental combo targets resistant cancer
NCT ID NCT06624085
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 27 times
Summary
This early-stage study tests a new drug called glofitamab combined with two chemotherapy drugs (gemcitabine and oxaliplatin) in 50 U.S. adults whose diffuse large B-cell lymphoma has come back or stopped responding to treatment. The goal is to see if the combination is safe and can shrink tumors. The study especially aims to include people from racial and ethnic groups that are often underrepresented in research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AdventHealth Cancer Institute
RECRUITINGOrlando, Florida, 32804, United States
-
Auxilio Mutuo Cancer Center
RECRUITINGSan Juan, 00917, Puerto Rico
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
-
Christus Health - Christus St. Vincent Regional Medical Center
RECRUITINGSanta Fe, New Mexico, 87505, United States
-
East Carolina University
RECRUITINGGreenville, North Carolina, 27834, United States
-
Georgetown University
RECRUITINGWashington D.C., District of Columbia, 20007, United States
-
Kansas City VA Medical Center
RECRUITINGKansas City, Kansas, 64128, United States
-
Renovatio Clinical
RECRUITINGThe Woodlands, Texas, 77380, United States
-
Renovatio Clinical - El Paso
RECRUITINGEl Paso, Texas, 79915, United States
-
Saddleback Memorial Medical Center
RECRUITINGLaguna Hills, California, 92653, United States
-
Thomas Jefferson University
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
UC San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
-
University of California Los Angeles (UCLA) - Cancer Care - Santa Monica
RECRUITINGSanta Monica, California, 90404-2023, United States
-
University of Illinois Cancer Center
RECRUITINGChicago, Illinois, 60612, United States
-
Walter Reed National Military Medical Center
RECRUITINGBethesda, Maryland, 20814, United States
-
Winship Cancer Institute of Emory University
RECRUITINGAtlanta, Georgia, 30329, United States
Conditions
Explore the condition pages connected to this study.